Monographie - Penicillin G sodium

Viimeisin päivitys :
19/11/2024

Penicillin G sodium

Kemiallinen rakenne

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Benapen	Brasilia
Bencilpenicilina	Chile, Ecuador, Marokko
Benpen	Australia, New Zealand
Bensylpenicillin	Ruotsi
Benzapen	Iran
Benzatec	Etelä-Afrikka
Benzatron	Brasilia
Benzylpenicillin	Egypti, Norja, Ruotsi, Suomi, Tanska
Benzylpenicilline	Tunisia
Biconcillina	Ecuador
Crystapen	Irlanti, Iso-Britannia, Kanada
Declin	Meksiko
Fortepen	Saudi-Arabia
Geepenil	Suomi
Natrium penicillin G	Hollanti
Novopen	Etelä-Afrikka
Pebencil	Venezuela
Penbendox	Meksiko
Penibiot	Espanja
Penicillin	Norja
Penicillina G sodica	Argentiina, Chile, Ecuador, Kolumbia, Portugali
Penilevel	Espanja
Sodiopen	Espanja
Unicillina	Espanja

Viitteet : Penicillin G sodium

	tyyppi	julkaisu
13	Lehti	Stiles ML, Allen LV. Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs. Am J Health-Syst Pharm 1997 ; 54: 1068-1070.
440	Lehti	Stiles ML, Tu YH, Allen LV. Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs. Am J Hosp Pharm 1989 ; 46: 1408-1412.
1057	Lehti	Cutie MR. Compatibility of verapamil hydrochloride injection with commonly used additives. Am J Hosp Pharm 1983 ; 40: 1205-1207.
1072	Lehti	Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA. Compatibility of levofloxacin with 34 medications during simulated Y-site administration. Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1241	Lehti	Rayani S, Jamali F. The stability of penicillin G sodium in 5% dextrose in water minibags after freezing. Can J Hosp Pharm 1985 ; 38: 162-163.
1263	Lehti	Allwood MC, Brown PW. The effect of buffering on the stability of reconstituted benzylpenicillin injection. Int J Pharm Pract 1992 ; 1: 242-244.
1725	Lehti	Oliver C, Law S. Compatibility of oxytocin, zidovudine, and penicillin G. Can J Hosp Pharm 2001 ; 54: 112-113.
2056	Lehti	Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST. Stability of benzylpenicillin during continuous home intravenous therapy. J Antimicrob Chemother 2004 ; 53: 675-677.
2087	Lehti	Ferreira E, Forest JM, Hildgen P. Compatibility of dimenhydrinate injectable by Y administration. Pharmactuel 2004 ; 37: 17-20.
2090	Lehti	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
3012	Lehti	Sullivan T, Forrest J.M, Leclair G. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration Hosp Pharm 2015 ; 50, 3: 214-220.
3227	Lehti	Simon B, Hancu G, Gy?resi A. Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
3520	Laboratorio	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3529	Laboratorio	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3540	Laboratorio	Heparin sodium - Summary of Product Characteristics. Wockhardt 2010
3549	Laboratorio	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3580	Laboratorio	Cytarabine Accord - Résumé des caractéristiques du produit Accord Healthcare France 2016
3585	Laboratorio	Benzylpenicillin sodium - Summary of Product Characteristics Genus Pharmaceuticals 2008
3643	Laboratorio	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3648	Lehti	Hossain M.A, Friciu M, Aubin S, Leclair G. Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers. Am J Health-Syst Pharm 2014 ; 71:669-673.
3674	Laboratorio	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3702	Lehti	McDougall D.A.J, McWhinney. Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy. J Pharm Pract and Res 2014 ; 44, 1: 26-28.
3931	Laboratorio	Trimébutine (Débridat®) - Résumé des caractéristiques du produit Pfizer Laboratoire 2016
3964	Lehti	Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G. Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Pharmactuel 2017 ; 50,1 : 27-33.
4154	Laboratorio	Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018
4319	Lehti	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4389	Lehti	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4590	Lehti	Smith E.K, McWhinney MPhil B.C. Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service. J Pediatr Pharmacol Ther 2021 ; 51: 231-237.
4603	Lehti	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.
4831	Lehti	Nezvalova-Henriksen K, Huseby Holm T, Nilsson N, Kjønniksen I, Tho I. Frequently acquired drugs in neonatal intensive care and their physical compatibility. Acta Paediatr 2022 ;111:2307–2314.
4837	Lehti	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.

Mentions Légales